1013559-24-4

Basic information

• Product Name: 4-(2-phenoxy-phenylsulfamoyl)-benzoic acid
• Synonyms: 4-(2-phenoxy-phenylsulfamoyl)-benzoic acid
• CAS NO: 1013559-24-4
• Molecular Weight: 369.398
• Mol File: 1013559-24-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(2-phenoxy-phenylsulfamoyl)-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-phenoxy-phenylsulfamoyl)-benzoic acid(1013559-24-4)
• EPA Substance Registry System: 4-(2-phenoxy-phenylsulfamoyl)-benzoic acid(1013559-24-4)

Safety Data

• Hazardous Substances Data: 1013559-24-4(Hazardous Substances Data)

Upstream product

• 10130-89-9 p-carboxyphenylsulfonyl chloride 
• 2688-84-8 2-phenoxyaniline 

Downstream Products

• 1021361-58-9 N-(4-[1,4']bipiperidinyl-1'-ylphenyl)-4-(2-phenoxyphenylsulfamoyl)benzamide 
• 1147098-98-3 (R)-2-[4-(2-phenoxy-phenylsulfamoyl)-benzoylamino]-propionic acid methyl ester 
• 1147098-78-9 (R)-N-{1-methyl-2-oxo-2-[4-(2-pyrrolidin-1-yl-ethyl)-piperidin-1-yl]-ethyl}-4-(2-phenoxy-phenylsulfamoyl)-benzamide 
• 1147098-99-4 (R)-2-[4-(2-phenoxy-phenylsulfamoyl)-benzoylamino]-propionic acid 

Relevant articles and documents

NON-PEPTIDE DERIVATIVES AS BRADYKININ B1 ANTAGONISTS

The present invention relates to new non-peptide derivatives of formula (I), wherein R1-R5, Q and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are sele

NEW PHENYLSULFAMOYL BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS

The present invention relates to new sulfonamide derivatives of formula (I), wherein R1-R8 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are selective antagonists of bradykinin B1, to processes for producing these same compounds, pharmacological compositions containing them and to their use in therapy or prevention of painful and inflammatory conditions.

NEW BENZAMIDE DERIVATIVES AS BRAD YKININ ANTAGONISTS

The present invention relates to new phenylsulfamoyl benzamide derivatives of formula (I), wherein R1-R5 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are selective antagonists of bradykinin B1, to processes for producing these compounds, to pharmacological compositions containing them and to their use in therapy or prevention of painful and inflammatory conditions.